{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:39:46Z","timestamp":1789015186678,"version":"build-2803163510"},"reference-count":5,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.leukres.2010.02.030","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T08:24:50Z","timestamp":1268900690000},"page":"e213-e214","source":"Crossref","is-referenced-by-count":7,"title":["Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia"],"prefix":"10.1016","volume":"34","author":[{"given":"Makoto","family":"Kashimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Ohyashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.02.030_bib1","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"Chronic myeloid leukemia: an update of concepts and management recommendations of European leukemia","volume":"27","author":"Baccarani","year":"2009","journal-title":"Net J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.02.030_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.02.030_bib3","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nature07016","article-title":"PML targeting eradicates quiescent leukaemia-initiating cells","volume":"453","author":"Ito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2010.02.030_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncb1717","article-title":"Arsenic degrades PML or PML\u2013RARalpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway","volume":"10","author":"Lallemand-Breitenbach","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.leukres.2010.02.030_bib5","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1073\/pnas.0813142106","article-title":"A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR\/ABL associated leukemia","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261000113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261000113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T14:22:41Z","timestamp":1544624561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521261000113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S014521261000113X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.02.030","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}